drugset / Trial / NCT04468230

Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy

NCT04468230

Phase 2 Terminated 4 enrolled Virginia Commonwealth University
NaSingle-groupOpen-labelSupportive care

Summary

Assess the efficacy of short-term nicotine transdermal patch administration for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer stable patients or patients in remission.

Timeline

Start
2020-07-31
Primary completion
2022-05-31
Completion
2022-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 7 mg Other
Subject Nicotine Unknown 14 mg Other